Trial Profile
A phase I study of adefovir and hydroxyurea [hydroxycarbamide] for refractory malignancies
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 18 Jan 2006
Price :
$35
*
At a glance
- Drugs Adefovir (Primary) ; Hydroxycarbamide (Primary)
- Indications Cancer
- Focus Adverse reactions
- 18 Jan 2006 New trial record.